NBD AI Bulletin - Sichuan Kelun Pharmaceutical Co Ltd ("the Company", SZ 002422, close pricing: 20.61 yuan) announced November 30 said that the Company has received a notice regarding share pledge and release of pledged stocks from controlling shareholder Mr. Liu Gexin. On November 26, Mr. Liu pledged 41.18 million shares, representing 10.86% of its holdings in the Company. On November 30, 2020, Mr. Liu released about 13.85 million pledged shares of the Company, accounting for 3.65% of its holdings.

The semi-annual report shows that Sichuan Kelun Pharmaceutical Co Ltd mainly engages in pharmaceutical manufacturing, accounting for 97.43% of its revenue.

Sichuan Kelun Pharmaceutical Co Ltd's chairman is Liu Gexin, male, 69 years old, Chinese national, no permanent residency abroad, graduate degree, senior engineer. Sichuan Kelun Pharmaceutical Co Ltd's general manager is Liu Sichuan, male, 36 years old, Chinese national, no permanent residency abroad, graduate degree.

Tips on "Stock Trends":

1. The number of shares held by northbound investors in the Company decreased by 3.4689 million in the past 30 days.

2. There was no institutional research on the Company in the past 30 days.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.